Affinium Pharmaceuticals

About:

Affinium Pharmaceuticals is a specialty pharmaceutical company, focused on the development of novel anti-infective medicines.

Website: http://www.afnm.com

Twitter/X: PINTSD

Top Investors: SV Health Investors, Forward Ventures, Oxford Bioscience Partners, Genesys Capital, The Ontario Capital Growth

Description:

Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the development of novel anti-infective medicines. The Affinium FASII antibacterial programs constitute a new antibiotic franchise with the potential for multiple products targeting the FASII pathway. These programs include a broad base of long-term intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors for a new class of antibiotics with a unique mechanism of action, targeting an underexploited pathway.

Total Funding Amount:

$81.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2000-01-01

Contact Email:

oroberts(AT)afnm.com

Founders:

Owen Roberts

Number of Employees:

11-50

Last Funding Date:

2013-09-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai